<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05045222</url>
  </required_header>
  <id_info>
    <org_study_id>20-010400</org_study_id>
    <nct_id>NCT05045222</nct_id>
  </id_info>
  <brief_title>Economic and Clinical Outcomes of (Whole Exome) Sequencing in Tapestry</brief_title>
  <acronym>ECOST</acronym>
  <official_title>ECOST = Economic and Clinical Outcomes of (Whole Exome) Sequencing in Tapestry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research is to learn more about the impact of genetic testing on&#xD;
      healthcare costs, clinical care, and quality of life.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 2021</start_date>
  <completion_date type="Anticipated">July 2032</completion_date>
  <primary_completion_date type="Anticipated">July 2031</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change in quality of life measured through adjusted years.</measure>
    <time_frame>Every 12 months for 5 years after enrollment.</time_frame>
    <description>Measuring quality of life through adjusted years due to learning Tapestry test results.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Disease incidence measured by disease count per 100 participants.</measure>
    <time_frame>12 months</time_frame>
    <description>Number of disease incidences per 100 participants.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in utilization measured by total number of office visits, hospital stays, ER visits, and length of visits.</measure>
    <time_frame>Every 12 months for 5 years after enrollment.</time_frame>
    <description>Composite of: Number of Office-based visits. Number of Hospital stays and length of visits. Number of ER visits.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in costs measured by disease related and all-cost related costs.</measure>
    <time_frame>Every 12 months for 5 years after enrollment.</time_frame>
    <description>Cost Composite of: Disease-related costs. Disease-related costs by utilization category. All-cause costs. All-cause costs by utilization category.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in quality of life measured through adjusted years from subgroups.</measure>
    <time_frame>Every 12 months for 5 years after enrollment.</time_frame>
    <description>Measuring quality of life through adjusted years due to learning Tapestry test results categorized by subgroups: minority races, 65 years and older, etc.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in quality of life measured through adjusted years from different scenarios.</measure>
    <time_frame>Every 12 months for 5 years after enrollment.</time_frame>
    <description>Measuring quality of life through adjusted years due to learning Tapestry test results categorized by different scenarios: disease comorbidities, patient income, education, adherence to medical orders, etc.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Disease incidence from subgroups.</measure>
    <time_frame>12 months</time_frame>
    <description>Number of disease incidences per 100 hundred participants categorized by subgroups: minority races, 65 years and older, etc.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Disease incidence from different scenarios..</measure>
    <time_frame>12 months</time_frame>
    <description>Number of disease incidences per 100 hundred participants categorized by different scenarios: disease comorbidities, patient income, education, adherence to medical orders, etc.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in utilization from subgroups.</measure>
    <time_frame>Every 12 months for 5 years after enrollment.</time_frame>
    <description>Composite of: Number of Office-based visits. Number of Hospital stays and length of visits. Number of ER visits. All categorized by subgroups: minority races, 65 years and older, etc.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in utilization from different scenarios.</measure>
    <time_frame>Every 12 months for 5 years after enrollment.</time_frame>
    <description>Composite of: Number of Office-based visits. Number of Hospital stays and length of visits. Number of ER visits. All categorized by different scenarios: disease comorbidities, patient income, education, adherence to medical orders, etc.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in costs from subgroups.</measure>
    <time_frame>Every 12 months for 5 years after enrollment.</time_frame>
    <description>All-cause costs. All-cause costs by utilization category. All categorized by subgroups: minority races, 65 years and older, etc.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in costs from different scenarios.</measure>
    <time_frame>Every 12 months for 5 years after enrollment.</time_frame>
    <description>All-cause costs. All-cause costs by utilization category. All categorized by different scenarios: disease comorbidities, patient income, education, adherence to medical orders, etc.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">100000</enrollment>
  <condition>Health Care Utilization</condition>
  <eligibility>
    <study_pop>
      <textblock>
        The study population will include participants of the Tapestry study, which is an ongoing&#xD;
        project aimed at studying the genetic risk factors that impact medical care of patients at&#xD;
        Mayo Clinic. This study will include the first 15,000 Tapestry patients who received&#xD;
        results of 11 genes (incidental findings) after undergoing WES using a saliva sample and&#xD;
        were enrolled January 2020 onwards. Chart review of up to 85,000 records will accompany the&#xD;
        15,000 enrolled and completing surveys for a total of 100,000 accrued.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Tapestry patients who have received genetic results, regardless of positive or&#xD;
             negative testing results.&#xD;
&#xD;
          -  Age of 18 and older.&#xD;
&#xD;
          -  Patients with an established Mayo Clinic provider prior to their enrollment in&#xD;
             Tapestry.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Individuals less than 18 years old.&#xD;
&#xD;
          -  Patients without capacity to consent (i.e., needing legal authorized representatives).&#xD;
&#xD;
          -  Prisoners.&#xD;
&#xD;
          -  Subjects eligible for chart review, without a Minnesota Research Authorization on&#xD;
             record.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Niloy Jewel Samadder, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Niloy Samadder</last_name>
      <phone>480-301-6990</phone>
      <email>Samadder.Jewel@mayo.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>July 28, 2021</study_first_submitted>
  <study_first_submitted_qc>September 14, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 16, 2021</study_first_posted>
  <last_update_submitted>October 21, 2021</last_update_submitted>
  <last_update_submitted_qc>October 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Niloy Jewel (Jewel) Samadder</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Tapestry</keyword>
  <keyword>Quality of life - adjusted life years</keyword>
  <keyword>ECOST</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

